Compare ARK Genomic Revolution ETF (ARKG) vs Weibo Corp (WB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Weibo Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Weibo Corp trades at $7.77 (market cap $1.89B). The key difference: Weibo Corp pays a 7.89% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Weibo Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | WB | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $12.83 |
52-Week Low | $23.09 | $7.20 |
Market Cap | — | $1.89B |
Enterprise Value | — | $1.16B |
Dividend Yield | — | 7.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Weibo (WB) trades at $7.72 with a bullish technical signal and strong valuation metrics, including a P/E of 5.41 and P/B of 0.49. Recent earnings missed estimates in three consecutive quarters, but the company maintains robust profitability with a 21.15% net income margin. A dividend of $0.61 was declared for H1 2026, supporting shareholder returns amid competitive pressures.
The stock presents value with deep undervaluation relative to cash flows and balance sheet strength, though user engagement challenges and rivalry from Douyin pose growth risks. Analyst consensus is mixed with 45% buy ratings, highlighting potential upside if execution improves, but investors face headwinds from China's regulatory environment and advertising volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
